Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Porter

Showing results (221-230 of 298) with videos related to

Pageof 30
Sort By:
Molecular Pharmaceutics|August 16, 2018
Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide LinkerDharmini Mehta, Nathania Leong, Victoria M McLeod, et al.
Frontiers in Pharmacology|May 2, 2022
Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic TransportTim Quach, Luojuan Hu, Sifei Han, et al.
ACS Applied Materials & Interfaces|July 21, 2021
Quantitatively Tracking Bio-Nano Interactions of Metal-Phenolic Nanocapsules by Mass CytometryShiyao Li, Yi Ju, Jiajing Zhou, et al.
Angewandte Chemie (International Ed. in English)|August 3, 2016
Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral BioavailabilityLuojuan Hu, Tim Quach, Sifei Han, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2019
Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulationEnyuan Cao, Anna Lindgren, Sofia Martinsson, et al.
Frontiers in Pharmacology|September 22, 2022
Corrigendum: Triglyceride-mimetic prodrugs of buprenorphine enhance oral bioavailability via promotion of lymphatic transportTim Quach, Luojuan Hu, Sifei Han, et al.
Pharmaceutical Research|June 6, 2022
Biocompatible Cationic Lipoamino Acids as Counterions for Oral Administration of API-Ionic LiquidsAnthony Lai, Nathania Leong, Dan Zheng, et al.
International Journal of Pharmaceutics|February 13, 2021
Stabilising disproportionation of lipophilic ionic liquid salts in lipid-based formulationsAnthony Lai, Yasemin Sahbaz, Leigh Ford, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 28, 2011
A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systemsLisa M Kaminskas, Victoria M McLeod, Brian D Kelly, et al.
ACS Applied Materials & Interfaces|September 26, 2017
Templated Polymer Replica Nanoparticles to Facilitate Assessment of Material-Dependent Pharmacokinetics and BiodistributionDanzi Song, Jiwei Cui, Huanli Sun, et al.
Pageof 30

Showing results (221-230 of 298) with videos related to

Sort By:
Pageof 30
Molecular Pharmaceutics|August 16, 2018
Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide LinkerDharmini Mehta, Nathania Leong, Victoria M McLeod, et al.
Frontiers in Pharmacology|May 2, 2022
Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic TransportTim Quach, Luojuan Hu, Sifei Han, et al.
ACS Applied Materials & Interfaces|July 21, 2021
Quantitatively Tracking Bio-Nano Interactions of Metal-Phenolic Nanocapsules by Mass CytometryShiyao Li, Yi Ju, Jiajing Zhou, et al.
Angewandte Chemie (International Ed. in English)|August 3, 2016
Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral BioavailabilityLuojuan Hu, Tim Quach, Sifei Han, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2019
Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulationEnyuan Cao, Anna Lindgren, Sofia Martinsson, et al.
Frontiers in Pharmacology|September 22, 2022
Corrigendum: Triglyceride-mimetic prodrugs of buprenorphine enhance oral bioavailability via promotion of lymphatic transportTim Quach, Luojuan Hu, Sifei Han, et al.
Pharmaceutical Research|June 6, 2022
Biocompatible Cationic Lipoamino Acids as Counterions for Oral Administration of API-Ionic LiquidsAnthony Lai, Nathania Leong, Dan Zheng, et al.
International Journal of Pharmaceutics|February 13, 2021
Stabilising disproportionation of lipophilic ionic liquid salts in lipid-based formulationsAnthony Lai, Yasemin Sahbaz, Leigh Ford, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 28, 2011
A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systemsLisa M Kaminskas, Victoria M McLeod, Brian D Kelly, et al.
ACS Applied Materials & Interfaces|September 26, 2017
Templated Polymer Replica Nanoparticles to Facilitate Assessment of Material-Dependent Pharmacokinetics and BiodistributionDanzi Song, Jiwei Cui, Huanli Sun, et al.
Pageof 30